15 Cryptococcus neoformans is an opportunistic human pathogen, which causes serious disease 16 in immunocompromised hosts. Infection with this pathogen is particularly relevant in HIV + 17 patients, where it leads to around 200,000 deaths per annum. A key feature of cryptococcal 18 pathogenesis is the ability of the fungus to survive and replicate within the phagosome of 19 macrophages, as well as its ability to escape via a novel non-lytic mechanism known as 20 vomocytosis. We have been exploring whether viral infection affects the interaction between 21 C. neoformans and macrophages. Here we show that viral infection enhances cryptococcal 22 vomocytosis without altering phagocytosis or intracellular proliferation of the fungus. This 23 effect occurs with distinct, unrelated human viral pathogens and is recapitulated when 24 macrophages are stimulated with the anti-viral cytokine interferon alpha (IFN). Importantly, 25 the effect is abrogated when type-I interferon signalling is blocked, thus underscoring the 2 26 importance of type-I interferons in this phenomenon. Our results highlight the importance of 27 incorporating specific context cues while studying host-pathogen interactions. By doing so, we 28 found that acute viral infection may trigger the release of latent cryptococci from intracellular 29 compartments, with significant consequences for disease progression. 30 31 Non-Technical Author Summary 32 Infectious diseases are typically studied in the laboratory in isolation, but in real life people 33 often encounter multiple infections simultaneously. Here we investigate how the innate 34 immune response to the fatal fungus Cryptococcus neoformans is influenced by viral 35 coinfection. Whilst virally-infected macrophages retain a normal capacity to engulf and kill 36 Cryptococci, they demonstrate a dramatically enhanced propensity to expel them via the 37 process known as non-lytic expulsion or vomocytosis. Activation of vomocytosis is 38 independent of the type of virus encountered, since both HIV and measles (two entirely 39 unrelated viral pathogens) trigger the same effect. Instead it is driven by interferon-, a generic 40 'antiviral' response, which signals back to the infected macrophage, triggering expulsion of the 41 fungus. We propose that this hitherto unobserved phenomenon represents a 'reprioritisation' 42 pathway for innate immune cells, by which they can alter the frequency with which they expel 43 one pathogen (Cryptococcus) depending on the level of threat from a secondary viral infection. 44 3 45 Introduction 46 47 Since their discovery in 1957 by Isaacs and Lindenmann (1), the antiviral effects of type I 48 interferons have been well documented (2-4). More recently, their roles in non-viral infections49 have been investigated (5, 6). Different bacterial stimuli have been shown to elicit type I 50 interferon production, and in turn these so called "antiviral cytokines" play a role in the 51 outcome of bacterial infections (7-9). This stems in part from the complex and sometimes 52 contr...